Endothelial progenitor cells in arthritis-associated vasculogenesis and atherosclerosis

Joint Bone Spine

Volumn 76, Issue 6, 2009, Pages 581-583

  Pákozdi, Angéla ^a,c   Besenyei, Timea ^a   Paragh, György ^a   Koch, Alisa E ^b,c   Szekanecz, Zoltán ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Atherosclerosis; Endothelial progenitor cells; Rheumatoid arthritis; Vasculogenesis

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTHRITIS; ATHEROSCLEROSIS; EDITORIAL; ENDOTHELIUM CELL; HUMAN; MORBIDITY; MORTALITY; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; STEM CELL;

ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; SYNOVIAL MEMBRANE;

EID: 71349084148     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.04.007     Document Type: Editorial

References (20)

1. Freedman S.B., and Isner J.M. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 33 (2001) 379-393
2. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
3. Shoenfeld Y., Gerli R., Doria A., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112 (2005) 3337-3347
4. Szekanecz Z., Kerekes G., Dér H., et al. Accelerated atherosclerosis in rheumatoid arthritis. Ann NY Acad Sci 1108 (2007) 349-358
5. Grisar J., Aletaha D., Steiner C.W., et al. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis 66 (2007) 1284-1288
6. Paleolog E. It's all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis?. Arthritis Res Ther 7 (2005) 270-272
7. Avouac J., Uzan G., Kahan A., et al. Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 75 (2008) 131-137
8. Gehling U.M., Ergun S., Schumacher U., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 (2000) 3106-3112
9. Rüger B., Giurea A., Wanivenhaus A.H., et al. Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 50 (2004) 2157-2166
10. Silverman M.D., Haas C.S., Rad A.M., et al. The role of vascular cell adhesion molecule 1/very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum 56 (2007) 1817-1826
11. Herbrig K., Haensel S., Oelschlaegel U., et al. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 65 (2006) 157-163
12. Petit I., Jin D., and Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28 (2007) 299-307
13. Ceradini D.J., and Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15 (2005) 57-63
14. Fan Y., Ye J., Shen F., et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 28 (2008) 90-98
15. Oh I.Y., Yoon C.H., Hur J., et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 110 (2007) 3891-3899
16. Akhavani M.A., Larsen H., and Paleolog E. Circulating endothelial progenitor cells link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis. Scand J Rheumatol 36 (2007) 83-90
17. Ablin J.N., Boguslavski V., Aloush V., et al. Effect of anti-TNFα treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 79 (2006) 2364-2369
18. Jacobsson L.T., Turesson C., Gülfe A., et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32 (2005) 1213-1218
19. Dixon WG, Watson KD, Lunt M, et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007;56:2905-12.
20. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967